Cargando...
Review of Meningococcal Group B Vaccines
No broadly effective vaccines are available for prevention of group B meningococcal disease, which account for > 50% of all cases. The group B capsule is an autoantigen and is not a suitable vaccine target. Outer-membrane vesicle (OMV) vaccines appear to be safe and effective but serum bactericid...
Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2010
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2820413/ https://ncbi.nlm.nih.gov/pubmed/20144017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/648966 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|